Arecor Therapeutics PLC 02 November 2023 Arecor Therapeutics plc ("Arecor" or the "Company") INHIBRX MILESTONE TRIGGERS...
Arecor Therapeutics PLC 01 November 2023 Arecor Therapeutics plc ("Arecor" or the "Group") Exercise of rollover options and...
Arecor Therapeutics PLC on Monday said that it has increased the number of subjects for its ongoing Phase One clinica ...
Arecor Therapeutics PLC 02 October 2023 Arecor Therapeutics plc ("Arecor" or the "Group") Arecor provides update on progress...
Arecor Therapeutics PLC 15 September 2023 Arecor Therapeutics plc ("Arecor" or the "Group") Arecor to present on Investor Meet...
The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately rep ...
Arecor Therapeutics PLC 14 September 2023 Arecor Therapeutics plc ("Arecor", the "Company" or the "Group") INTERIM...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
By Joe Hoppe Arecor Therapeutics said that Hikma Pharmaceuticals has had a positive pre-investigational new drug application meeting with the U.S...
Arecor Therapeutics PLC 07 September 2023 Arecor Therapeutics plc ("Arecor" or the "Group") ARECOR ANNOUNCES POSITIVE PRE-IND...
Arecor Therapeutics PLC on Monday reported that its subsidiary Tetris Pharma Ltd has established an exclusive commerc ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.